$AMTX

Aemetis stock rises on India biodiesel supply deal

Aemetis Inc (NASDAQ:AMTX) shares rose 4.3% after its India unit, Universal Biofuels, secured about $17 million in biodiesel supply contracts. Over three months it will deliver more than 18 million liters to India’s three government-owned Oil Marketing Companies, supporting a policy to raise biodiesel blending to 5% by 2030. Additional orders are expected through 2026.

Original reporting
Published Aug 4, 2026, 4:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 5:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AMTX
Bullish
medium confidence
Mentioned
$AMTX
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AMTXBullishMed
01

Why it matters

The disclosed biodiesel supply contracts provide a concrete, time-bounded revenue stream and may improve near-term visibility for additional orders through 2026, supporting the stock’s momentum.

02

Market read

Traders can treat the $17 million contract as a fresh catalyst for AMTX, with the next decision point being whether additional OMC orders are announced before year-end 2026.

03

What to watch

Key sensitivities are execution risk at the Kakinada facility, potential changes in India biodiesel offtake terms, and whether the “additional OMC orders anticipated” actually convert into signed contracts.

Relevance 7/10Novelty 7/10Timing: today, after-hours/next-session reaction to the newly announced $17 million India biodiesel contracts

Background

Aemetis’ Universal Biofuels unit operates a biodiesel production facility in Kakinada and is tied to India’s biofuel blending policy.

Company-level read

Ticker impact

$AMTXBullishMedium confidence
Context

Aemetis shares rose 4.3% after its India subsidiary secured about $17 million of biodiesel supply contracts for three months.

Expected impact

Likely positive near-term bias, with follow-through dependent on whether additional OMC orders materialize before year-end 2026.

Evidence & confidence

The article provides deal size ($17 million), delivery volume (more than 18 million liters), and a stated expectation of additional OMC orders, which can drive incremental sentiment and estimates.

Market effects

Reinforces demand visibility for biodiesel producers tied to India’s National Policy on Biofuels and blending targets.

Highlights incremental supply contracting activity in India’s government-linked oil marketing channel.

Supports the broader renewable fuels narrative, though the disclosed contract is region-specific and moderate in size.

Counterpoint

The contract is only for a three-month window and the article does not confirm margins, pricing, or whether the $17 million is incremental versus already-planned volumes.

Key entities

  • Aemetis Inc

    NASDAQ-listed biodiesel producer whose India subsidiary secured biodiesel supply contracts worth about $17 million.

  • Universal Biofuels

    Aemetis India unit delivering more than 18 million liters of biodiesel to India’s government-owned Oil Marketing Companies over three months.

  • India’s Oil Marketing Companies (OMCs)

    Government-owned offtakers receiving biodiesel deliveries under the National Policy on Biofuels.

Related articles

$AMTXMedAI 8/10

Aemetis (AMTX) Q2 2026 Earnings Call Transcript

Aemetis (AMTX) reported Q2 2026 revenue of $62.7M, up 20% YoY, with operating income of $5.8M, reversing a prior-year loss. Growth was driven by ethanol and renewable natural gas segments. Adjusted EBITDA improved to $9.7M from -$5.8M. Management highlighted projects like mechanical vapor recompression and LCFS pathway approvals, but noted risks from uncertain emissions rates and feedstock constraints.

$AMTXMed

Aemetis (AMTX) Q2 2026 Earnings Call Transcript

Aemetis (AMTX) Q2 2026 earnings call said consolidated revenue rose 20% year over year, operating income improved by $16.4 million, and adjusted EBITDA increased by $15.5 million versus Q2 2025. The company cited CARB approval of 7 LCFS pathways and pending approvals for 6 digesters, plus ethanol projects including a $32 million annual cash flow MVR system. India biodiesel revenue was $2.5 million, with expected $17 million from new allocations.

$AMTXMed

Aemetis Q2 2026 Earnings: Financial Results, Revenue, and Segment Performance Highlights – Minichart

Aemetis reported Q2 2026 revenue of $62.7 million, up $10.5 million (20%) from Q2 2025, including $8.6 million from Section 45Z tax credits. Operating income improved by $16.4 million, net loss narrowed to $9.4 million, and adjusted EBITDA rose to $9.7 million. The company is pursuing refinancing and financing for its Keyes ethanol and Dairy RNG projects, and is considering an IPO for its India unit.

$AMTXMed

AEMETIS, INC (AMTX): Results of Operations and Financial Condition

AEMETIS, INC (AMTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 ksmith@pcgadvisory.com Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 investors@aemetis.com Aemetis Reports Second Quarter 2026 Financial Results Revenue Growth o